ACE2 and COVID-19: While some studies suggest that IBD increases ACE2 expression in the gastrointestinal tract, others dispute this claim; however, ulcerative colitis (UC), a subtype of IBD, research found a relationship with IBD with a higher ACE2 expression and an increased risk of severe COVID-19 outcomes, including hospitalization and mortality.